Metastatic disease, eye retention and visual function in conservative treatment of uveal melanoma.
Bornfeld
N
N
Universitätsklinikum Benjamin Franklin, Freie Universität, Berlin, Germany.
Chauvel
P
P
Sauerwein
W
W
Friedrichs
W
W
Tiburtius
T
T
Wessing
A
A
Foerster
M H
MH
D001766:Blindness / Q000209:etiology; D001918:Brachytherapy / Q000009:adverse effects* / Q000379:methods; D002924:Ciliary Body / Q000473:pathology* / Q000528:radiation effects; D015353:Eye Enucleation; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008545:Melanoma / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D008875:Middle Aged; D015999:Multivariate Analysis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000628:therapy; D011379:Prognosis; D011832:Radiation Injuries / Q000209:etiology / Q000628:therapy; D012189:Retrospective Studies; D012307:Risk Factors; D012429:Ruthenium Radioisotopes / Q000627:therapeutic use; D016879:Salvage Therapy; D014604:Uveal Neoplasms / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D014792:Visual Acuity
D007457:Iodine Radioisotopes; D012429:Ruthenium Radioisotopes